Articles Tagged With:
-
Successful CHW Programs Are Complex and Require Meticulous Planning
Successful community health worker programs don’t just happen by magic: Providers have to plan the initiative carefully and be clear about the roles and responsibilities.
-
Who Are Community Health Workers?
If your hospital doesn’t have its own community-based workers to support at-risk patients, you should research the providers in the community and what services they can offer.
-
Your New Best Friend May Be a Community Health Worker
Community health workers, lay people who live in the community they serve and understand the challenges of the people who live there, can teach at-risk patients how to navigate the healthcare system, help them obtain community services, and support them in overcoming obstacles to care.
-
FDA Takes Aim at Nicotine Levels in Cigarettes
The agency wants to lower the amount of the addictive chemical to further reduce smoking rates.
-
Atrial Flutter or Atrial Tachycardia?
-
Clinical Briefs
In this section: nonsteroidal anti-inflammatory drugs and gastrointestinal bleeding; rheumatoid arthritis; and community-acquired pneumonia.
-
Delafloxacin Tablets (Baxdela)
Delafloxacin is indicated for the treatment of acute bacterial skin and skin structure infections caused by susceptible organisms.
-
Atypical Transient Symptoms Require Aggressive Investigation for Cause
Atypical transient symptoms, such as partial sensory deficit, dysarthria, vertigo and unsteadiness, unusual visual deficits, and diplopia, usually are not classified as transient ischemic attacks, and they frequently are not investigated in the same fashion.
-
Glycemic Measures May Vary Depending on Race
In patients with type 1 diabetes, hemoglobin A1c levels overestimate the mean glucose concentration in black persons compared with white persons, possibly owing to racial differences in the glycation of hemoglobin.
-
Long-term Use of Proton Pump Inhibitors and Earlier Death
An observational study of a Veterans Affairs population showed that the use of proton pump inhibitors over a median 5.7-year follow-up period increased the risk of death by 25% compared with the use of histamine 2 blockers or no medication.